Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine on blood loss and patient outcomes in orthognathic surgery
TCTR20230818002Phase 4Completed
- Sponsor
- self support
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, sponsored by self support. Started Sep 2023; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on TCTR20230818002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230818002.